So true, and DM also, not changing his spots, had to be cheeky to throw that performance shares entitlement at revenues >$100m designed to create impression of strong growth ahead. LIFX results are unaudited and people should wait to see if the recent quarterly surge in revenues (note substantial increase in accounts receivables) can sustain into the next quarters ahead.
It will continue to be challenging for them to grow revenues substantial enough to cover expenses (both LIFX and BUD expenses), and cashflow would be the main challenge what more with additional debts thrown in.
BUD Price at posting:
8.0¢ Sentiment: Sell Disclosure: Not Held